# pathway_0081: before and after transfer clarification

[All 1,328 cases](../README.md) · [Method](../METHOD.md) · [Summary](../SUMMARY.md) · [Exact reviewer user message](../inputs/pathway_0081.txt)

**Task:** `pathway`  
**Author key, unchanged:** **A** — Antifungal biosynthesis. .

| Round | Reviewer | Key support | Transfer / lookup | Output usability (canonical status) |
|---|---|---|---|---|
| before | GPT-6 Luna | supported | lookup-dependent | usable output (valid_review) |
| before | Qwen3.8-Flash-Next-NVFP4 | supported | lookup-dependent | usable output (valid_review) |
| after | GPT-6 Luna | supported | reasoning-supported | usable output (valid_review) |
| after | Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | usable output (valid_review) |

**Usable output means format-valid review, not reasoning-supported or biologically correct.** A usable output can classify the question as reasoning-supported, lookup-dependent or uncertain. An output error is a problem with the saved model response; it does not count a defective benchmark question or wrong key. Each saved review is retained in full below. Labels from output errors are displayed as saved and excluded from label statistics. The author key and reviewer evidence were visible to reviewers; this is a review of answerability and key support, not a benchmark-solving score.

## Complete original question

```text
[Protein Sequence]
MQAIISTAPGQAALVHDRPLPTIRDGYLLVKTKAVALNPTDWKHIEVTQKPGILFGCDYAGIVEQVGPGVQSGFQPGDRVAGFVHGGNSKEPQDGAFAEYIVAKADLQIHIPEHMSFEEAATLGVGITAVGQGLYQTLSLPFPSPSSIHEDGAEKPANPATQPILIYGASTASGVLGIQFAKLSGFAPLAVCSPDHFDLAERLGAVAVFDYADGEDAVEEIQDYVRGMGQPLLKAWDTISIPSSARFCGDALSSGNGPQYASLLSMTCPRPDVTSTTTMAYTVFGEDWGMGTAHFPASGVDAELGRRWWALVQQLLNEGRIQTHRIIAGEGGLDGVLGGLQQLRDSQVRGGKLVFRV

[Multiple Choices]
A. Antifungal biosynthesis. .
B. 5-methoxycarbonylmethyl-2-thiouridine-tRNA biosynthesis. .
C. L-valine from pyruvate: step 3/4. .
D. One-carbon metabolism
```

<details>
<summary>Complete original system instructions</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Protein Pathway Prediction, which is to predict the primary metabolic or signaling pathway in which a given protein functions. Biological pathways are series of chemical reactions occurring within a cell that are essential for life. Based on the protein's amino acid sequence, you should identify the most relevant pathway from the given options.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## Four saved visible reviews

## Before: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> A sequence-matched UniProt record annotates the protein's pathway as antifungal biosynthesis, with ECO:0000269 evidence linked to a publication. The archived record also carries this annotation. This supports the key, though the supplied evidence does not independently validate the underlying experiment.

Citations as saved: [C5](#evidence-c5), [H3](#evidence-h3), [H2](#evidence-h2).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence is compatible with an enzyme, but its amino-acid sequence alone does not establish the specific biosynthetic cluster or pathway in which it functions.


**Missing item-specific fact**

> The protein-specific annotation or experimental finding identifying this sequence as ResD, a restricticin-biosynthesis cluster protein associated with antifungal biosynthesis.


**Reason**

> Selecting A depends on a protein-specific pathway assignment absent from the input. Recognizing or retrieving the exact sequence's database annotation is lookup, not a biological argument supplied by the question.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The reviewer evidence supports A; no other choice is supported as the protein's primary pathway. The input itself does not provide enough context to distinguish the pathway without protein-specific information.


### Important caveats

- The benchmark sequence exactly matches the historical and current UniProt sequence, but the author's source snapshot is unknown.
- The pathway annotation is linked to a publication and marked with experimental evidence; the cited study was not independently assessed here.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence is compatible with an enzyme, but its amino-acid sequence alone does not establish the specific biosynthetic cluster or pathway in which it functions.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein-specific annotation or experimental finding identifying this sequence as ResD, a restricticin-biosynthesis cluster protein associated with antifungal biosynthesis.",
    "reason": "Selecting A depends on a protein-specific pathway assignment absent from the input. Recognizing or retrieving the exact sequence's database annotation is lookup, not a biological argument supplied by the question."
  },
  "case_id": "pathway_0081",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H3",
      "H2"
    ],
    "judgment": "supported",
    "reason": "A sequence-matched UniProt record annotates the protein's pathway as antifungal biosynthesis, with ECO:0000269 evidence linked to a publication. The archived record also carries this annotation. This supports the key, though the supplied evidence does not independently validate the underlying experiment."
  },
  "important_caveats": [
    "The benchmark sequence exactly matches the historical and current UniProt sequence, but the author's source snapshot is unknown.",
    "The pathway annotation is linked to a publication and marked with experimental evidence; the cited study was not independently assessed here."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The reviewer evidence supports A; no other choice is supported as the protein's primary pathway. The input itself does not provide enough context to distinguish the pathway without protein-specific information."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0081",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "A sequence-matched UniProt record annotates the protein's pathway as antifungal biosynthesis, with ECO:0000269 evidence linked to a publication. The archived record also carries this annotation. This supports the key, though the supplied evidence does not independently validate the underlying experiment.",
    "evidence_ids": ["C5", "H3", "H2"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence is compatible with an enzyme, but its amino-acid sequence alone does not establish the specific biosynthetic cluster or pathway in which it functions.",
    "missing_item_specific_fact": "The protein-specific annotation or experimental finding identifying this sequence as ResD, a restricticin-biosynthesis cluster protein associated with antifungal biosynthesis.",
    "reason": "Selecting A depends on a protein-specific pathway assignment absent from the input. Recognizing or retrieving the exact sequence's database annotation is lookup, not a biological argument supplied by the question."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The reviewer evidence supports A; no other choice is supported as the protein's primary pathway. The input itself does not provide enough context to distinguish the pathway without protein-specific information."
  },
  "important_caveats": [
    "The benchmark sequence exactly matches the historical and current UniProt sequence, but the author's source snapshot is unknown.",
    "The pathway annotation is linked to a publication and marked with experimental evidence; the cited study was not independently assessed here."
  ]
}
```

</details>

## Before: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> UniProt entry P0DXV9 (RESD_ASPSL) carries a PATHWAY annotation of 'Antifungal biosynthesis' with evidence code ECO:0000269 (experimental evidence) from PubMed:39105744 (2024 paper characterizing the restricticin biosynthesis cluster in Aspergillus sclerotiorum). The protein is annotated as 'Trans-enoyl reductase resD' / 'Restricticin biosynthesis cluster protein D.' The benchmark sequence matches the canonical entry (357 AA, SHA256 confirmed). The pathway annotation is experimentally supported.

Citations as saved: [C5](#evidence-c5), [H3](#evidence-h3), [C4](#evidence-c4), [C6](#evidence-c6).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence contains trans-enoyl reductase motifs (e.g., GASTASG NAD(P)-binding motif, GADGEDA reductase signature). A model could argue by elimination that trans-enoyl reductases are not found in tRNA thiolation (B), L-valine biosynthesis (C), or one-carbon metabolism (D), making A the only remaining option. However, positively identifying 'Antifungal biosynthesis' as THE pathway (rather than fatty acid biosynthesis, general polyketide biosynthesis, or other secondary metabolite pathways) requires knowing this specific protein belongs to the restricticin cluster in A. sclerotiorum.


**Missing item-specific fact**

> The specific experimental characterization (PubMed:39105744) that placed resD within the restricticin biosynthesis cluster and assigned the pathway label 'Antifungal biosynthesis.' Without this, a trans-enoyl reductase in a fungal genome could be annotated to multiple secondary metabolite pathways or fatty acid biosynthesis.


**Reason**

> While elimination of clearly incompatible distractors (B, C, D) is partially possible from general knowledge of enzyme families, the positive identification of 'Antifungal biosynthesis' as the pathway label for this specific trans-enoyl reductase depends on the item-specific experimental annotation from the 2024 restricticin cluster study. The sequence alone identifies a reductase but does not uniquely specify 'antifungal' biosynthesis over other reductase-containing pathways.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The three distractors (tRNA thiolation, L-valine biosynthesis step 3/4, one-carbon metabolism) are clearly incompatible with a trans-enoyl reductase domain architecture. No other option is defensible for this protein type.


### Important caveats

- The pathway annotation 'Antifungal biosynthesis' is a broad UniProt-level label; the specific compound is restricticin, identified experimentally in 2024.
- The entry was first public in February 2025, so this is a relatively recent annotation; the author's source snapshot is unknown but the sequence and annotation are consistent across entry versions 4 and 6.
- The evidence code ECO:0000269 confirms experimental (not purely computational) support for the pathway assignment.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence contains trans-enoyl reductase motifs (e.g., GASTASG NAD(P)-binding motif, GADGEDA reductase signature). A model could argue by elimination that trans-enoyl reductases are not found in tRNA thiolation (B), L-valine biosynthesis (C), or one-carbon metabolism (D), making A the only remaining option. However, positively identifying 'Antifungal biosynthesis' as THE pathway (rather than fatty acid biosynthesis, general polyketide biosynthesis, or other secondary metabolite pathways) requires knowing this specific protein belongs to the restricticin cluster in A. sclerotiorum.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The specific experimental characterization (PubMed:39105744) that placed resD within the restricticin biosynthesis cluster and assigned the pathway label 'Antifungal biosynthesis.' Without this, a trans-enoyl reductase in a fungal genome could be annotated to multiple secondary metabolite pathways or fatty acid biosynthesis.",
    "reason": "While elimination of clearly incompatible distractors (B, C, D) is partially possible from general knowledge of enzyme families, the positive identification of 'Antifungal biosynthesis' as the pathway label for this specific trans-enoyl reductase depends on the item-specific experimental annotation from the 2024 restricticin cluster study. The sequence alone identifies a reductase but does not uniquely specify 'antifungal' biosynthesis over other reductase-containing pathways."
  },
  "case_id": "pathway_0081",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H3",
      "C4",
      "C6"
    ],
    "judgment": "supported",
    "reason": "UniProt entry P0DXV9 (RESD_ASPSL) carries a PATHWAY annotation of 'Antifungal biosynthesis' with evidence code ECO:0000269 (experimental evidence) from PubMed:39105744 (2024 paper characterizing the restricticin biosynthesis cluster in Aspergillus sclerotiorum). The protein is annotated as 'Trans-enoyl reductase resD' / 'Restricticin biosynthesis cluster protein D.' The benchmark sequence matches the canonical entry (357 AA, SHA256 confirmed). The pathway annotation is experimentally supported."
  },
  "important_caveats": [
    "The pathway annotation 'Antifungal biosynthesis' is a broad UniProt-level label; the specific compound is restricticin, identified experimentally in 2024.",
    "The entry was first public in February 2025, so this is a relatively recent annotation; the author's source snapshot is unknown but the sequence and annotation are consistent across entry versions 4 and 6.",
    "The evidence code ECO:0000269 confirms experimental (not purely computational) support for the pathway assignment."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The three distractors (tRNA thiolation, L-valine biosynthesis step 3/4, one-carbon metabolism) are clearly incompatible with a trans-enoyl reductase domain architecture. No other option is defensible for this protein type."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0081",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProt entry P0DXV9 (RESD_ASPSL) carries a PATHWAY annotation of 'Antifungal biosynthesis' with evidence code ECO:0000269 (experimental evidence) from PubMed:39105744 (2024 paper characterizing the restricticin biosynthesis cluster in Aspergillus sclerotiorum). The protein is annotated as 'Trans-enoyl reductase resD' / 'Restricticin biosynthesis cluster protein D.' The benchmark sequence matches the canonical entry (357 AA, SHA256 confirmed). The pathway annotation is experimentally supported.",
    "evidence_ids": ["C5", "H3", "C4", "C6"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence contains trans-enoyl reductase motifs (e.g., GASTASG NAD(P)-binding motif, GADGEDA reductase signature). A model could argue by elimination that trans-enoyl reductases are not found in tRNA thiolation (B), L-valine biosynthesis (C), or one-carbon metabolism (D), making A the only remaining option. However, positively identifying 'Antifungal biosynthesis' as THE pathway (rather than fatty acid biosynthesis, general polyketide biosynthesis, or other secondary metabolite pathways) requires knowing this specific protein belongs to the restricticin cluster in A. sclerotiorum.",
    "missing_item_specific_fact": "The specific experimental characterization (PubMed:39105744) that placed resD within the restricticin biosynthesis cluster and assigned the pathway label 'Antifungal biosynthesis.' Without this, a trans-enoyl reductase in a fungal genome could be annotated to multiple secondary metabolite pathways or fatty acid biosynthesis.",
    "reason": "While elimination of clearly incompatible distractors (B, C, D) is partially possible from general knowledge of enzyme families, the positive identification of 'Antifungal biosynthesis' as the pathway label for this specific trans-enoyl reductase depends on the item-specific experimental annotation from the 2024 restricticin cluster study. The sequence alone identifies a reductase but does not uniquely specify 'antifungal' biosynthesis over other reductase-containing pathways."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The three distractors (tRNA thiolation, L-valine biosynthesis step 3/4, one-carbon metabolism) are clearly incompatible with a trans-enoyl reductase domain architecture. No other option is defensible for this protein type."
  },
  "important_caveats": [
    "The pathway annotation 'Antifungal biosynthesis' is a broad UniProt-level label; the specific compound is restricticin, identified experimentally in 2024.",
    "The entry was first public in February 2025, so this is a relatively recent annotation; the author's source snapshot is unknown but the sequence and annotation are consistent across entry versions 4 and 6.",
    "The evidence code ECO:0000269 confirms experimental (not purely computational) support for the pathway assignment."
  ]
}
```

</details>

## After: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The sequence matches the cited UniProt record, whose pathway annotation assigns it to antifungal biosynthesis with experimental evidence code ECO:0000269. The record links that annotation to a publication covering function and pathway; the paper itself was not independently reviewed here.

Citations as saved: [C5](#evidence-c5), [H3](#evidence-h3), [C6](#evidence-c6).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence is consistent with a trans-enoyl-reductase-type enzyme. Transferable knowledge associates such reductases with specialized metabolite assembly, making antifungal biosynthesis a better fit than tRNA modification, branched-chain amino-acid synthesis, or one-carbon metabolism among these choices. This is a probabilistic family-level inference, not proof of the antifungal product.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> A reductase-family inference can meaningfully separate the offered specialized-metabolite option from the three choices describing distinct primary or RNA-modification pathways, even though the precise pathway and product are not established by sequence alone.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The alternatives describe substantially different pathway types, and the enzyme-family inference favors A among those offered.


### Important caveats

- Reviewer-only annotations support the key but were not part of the original model input.
- The pathway assignment is linked to an experimental evidence code in UniProt; the underlying publication was not independently evaluated.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence is consistent with a trans-enoyl-reductase-type enzyme. Transferable knowledge associates such reductases with specialized metabolite assembly, making antifungal biosynthesis a better fit than tRNA modification, branched-chain amino-acid synthesis, or one-carbon metabolism among these choices. This is a probabilistic family-level inference, not proof of the antifungal product.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "A reductase-family inference can meaningfully separate the offered specialized-metabolite option from the three choices describing distinct primary or RNA-modification pathways, even though the precise pathway and product are not established by sequence alone."
  },
  "case_id": "pathway_0081",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H3",
      "C6"
    ],
    "judgment": "supported",
    "reason": "The sequence matches the cited UniProt record, whose pathway annotation assigns it to antifungal biosynthesis with experimental evidence code ECO:0000269. The record links that annotation to a publication covering function and pathway; the paper itself was not independently reviewed here."
  },
  "important_caveats": [
    "Reviewer-only annotations support the key but were not part of the original model input.",
    "The pathway assignment is linked to an experimental evidence code in UniProt; the underlying publication was not independently evaluated."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The alternatives describe substantially different pathway types, and the enzyme-family inference favors A among those offered."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0081",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The sequence matches the cited UniProt record, whose pathway annotation assigns it to antifungal biosynthesis with experimental evidence code ECO:0000269. The record links that annotation to a publication covering function and pathway; the paper itself was not independently reviewed here.",
    "evidence_ids": ["C5", "H3", "C6"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence is consistent with a trans-enoyl-reductase-type enzyme. Transferable knowledge associates such reductases with specialized metabolite assembly, making antifungal biosynthesis a better fit than tRNA modification, branched-chain amino-acid synthesis, or one-carbon metabolism among these choices. This is a probabilistic family-level inference, not proof of the antifungal product.",
    "missing_item_specific_fact": "",
    "reason": "A reductase-family inference can meaningfully separate the offered specialized-metabolite option from the three choices describing distinct primary or RNA-modification pathways, even though the precise pathway and product are not established by sequence alone."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The alternatives describe substantially different pathway types, and the enzyme-family inference favors A among those offered."
  },
  "important_caveats": [
    "Reviewer-only annotations support the key but were not part of the original model input.",
    "The pathway assignment is linked to an experimental evidence code in UniProt; the underlying publication was not independently evaluated."
  ]
}
```

</details>

## After: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The UniProt entry P0DXV9 explicitly annotates the pathway as 'Antifungal biosynthesis' with evidence code ECO:0000269 (experimental evidence, PubMed:39105744). The protein is named 'Trans-enoyl reductase resD' and described as part of the 'Restricticin biosynthesis cluster' (restricticin being an antifungal compound). The sequence in the question matches the reviewed entry exactly (357 AA, SHA256 matched). The annotation is experimentally supported.

Citations as saved: [C5](#evidence-c5), [H3](#evidence-h3), [C4](#evidence-c4), [C6](#evidence-c6).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence contains recognizable enoyl reductase (ER) domain features: a Rossmann-like NAD(P)H-binding motif ('GASTASGVLGIQFAKLSGFAPLA' with GxxGxxG spacing) and the catalytic YXXXD motif ('YTVFGEDWGMGTAHFPASGVDA'). Enoyl reductase domains are characteristic of polyketide synthase (PKS) and fatty acid synthase (FAS) biosynthetic machinery. This domain architecture is fundamentally incompatible with: (B) tRNA modification enzymes (which use radical SAM, thiolation, or methyltransferase folds); (C) dihydroxy-acid dehydratase for valine biosynthesis (an Fe-S cluster enzyme with a completely different fold); (D) one-carbon metabolism enzymes (SHMT, MTHFR, formyltransferases — none have ER domains). In fungi, standalone ER domains (not embedded in large FAS/PKS multi-domain proteins) are predominantly found in secondary metabolite biosynthetic gene clusters, many of which produce antifungal or antimicrobial compounds. Among the four options, only 'Antifungal biosynthesis' (A) is compatible with an enoyl reductase domain in a fungal protein context.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> The enoyl reductase domain features in the sequence allow elimination of options B, C, and D through domain-incompatibility reasoning. The positive assignment to 'Antifungal biosynthesis' follows from the transferable knowledge that standalone ER domains in fungal proteins are typically embedded in specialized secondary metabolite clusters, a large fraction of which produce antifungal compounds. This is a family-level inference from ER domain biology and fungal natural product chemistry, not a lookup of this specific protein's annotation.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The enoyl reductase domain is clearly incompatible with tRNA modification (B), amino acid biosynthesis (C), and one-carbon metabolism (D). Only option A is compatible with the observed domain architecture. No ambiguity among the offered choices.


### Important caveats

- The positive identification of 'antifungal' specifically (rather than, say, 'polyketide biosynthesis' or 'fatty acid biosynthesis') relies on the elimination of the other three options plus the probabilistic association of fungal standalone ER domains with secondary metabolite clusters. The sequence alone does not encode 'antifungal' as a specific property.
- The UniProt annotation is from a 2024 experimental study (PubMed:39105744) characterizing the restricticin biosynthetic cluster in Aspergillus sclerotiorum. The pathway label 'Antifungal biosynthesis' is a UniProt-curated descriptor for this specific natural product pathway.
- The reviewer-only evidence confirms the sequence matches P0DXV9 exactly, but the organism identity and specific compound name (restricticin) were not provided to the evaluated model.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence contains recognizable enoyl reductase (ER) domain features: a Rossmann-like NAD(P)H-binding motif ('GASTASGVLGIQFAKLSGFAPLA' with GxxGxxG spacing) and the catalytic YXXXD motif ('YTVFGEDWGMGTAHFPASGVDA'). Enoyl reductase domains are characteristic of polyketide synthase (PKS) and fatty acid synthase (FAS) biosynthetic machinery. This domain architecture is fundamentally incompatible with: (B) tRNA modification enzymes (which use radical SAM, thiolation, or methyltransferase folds); (C) dihydroxy-acid dehydratase for valine biosynthesis (an Fe-S cluster enzyme with a completely different fold); (D) one-carbon metabolism enzymes (SHMT, MTHFR, formyltransferases — none have ER domains). In fungi, standalone ER domains (not embedded in large FAS/PKS multi-domain proteins) are predominantly found in secondary metabolite biosynthetic gene clusters, many of which produce antifungal or antimicrobial compounds. Among the four options, only 'Antifungal biosynthesis' (A) is compatible with an enoyl reductase domain in a fungal protein context.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "The enoyl reductase domain features in the sequence allow elimination of options B, C, and D through domain-incompatibility reasoning. The positive assignment to 'Antifungal biosynthesis' follows from the transferable knowledge that standalone ER domains in fungal proteins are typically embedded in specialized secondary metabolite clusters, a large fraction of which produce antifungal compounds. This is a family-level inference from ER domain biology and fungal natural product chemistry, not a lookup of this specific protein's annotation."
  },
  "case_id": "pathway_0081",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H3",
      "C4",
      "C6"
    ],
    "judgment": "supported",
    "reason": "The UniProt entry P0DXV9 explicitly annotates the pathway as 'Antifungal biosynthesis' with evidence code ECO:0000269 (experimental evidence, PubMed:39105744). The protein is named 'Trans-enoyl reductase resD' and described as part of the 'Restricticin biosynthesis cluster' (restricticin being an antifungal compound). The sequence in the question matches the reviewed entry exactly (357 AA, SHA256 matched). The annotation is experimentally supported."
  },
  "important_caveats": [
    "The positive identification of 'antifungal' specifically (rather than, say, 'polyketide biosynthesis' or 'fatty acid biosynthesis') relies on the elimination of the other three options plus the probabilistic association of fungal standalone ER domains with secondary metabolite clusters. The sequence alone does not encode 'antifungal' as a specific property.",
    "The UniProt annotation is from a 2024 experimental study (PubMed:39105744) characterizing the restricticin biosynthetic cluster in Aspergillus sclerotiorum. The pathway label 'Antifungal biosynthesis' is a UniProt-curated descriptor for this specific natural product pathway.",
    "The reviewer-only evidence confirms the sequence matches P0DXV9 exactly, but the organism identity and specific compound name (restricticin) were not provided to the evaluated model."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The enoyl reductase domain is clearly incompatible with tRNA modification (B), amino acid biosynthesis (C), and one-carbon metabolism (D). Only option A is compatible with the observed domain architecture. No ambiguity among the offered choices."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0081",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The UniProt entry P0DXV9 explicitly annotates the pathway as 'Antifungal biosynthesis' with evidence code ECO:0000269 (experimental evidence, PubMed:39105744). The protein is named 'Trans-enoyl reductase resD' and described as part of the 'Restricticin biosynthesis cluster' (restricticin being an antifungal compound). The sequence in the question matches the reviewed entry exactly (357 AA, SHA256 matched). The annotation is experimentally supported.",
    "evidence_ids": ["C5", "H3", "C4", "C6"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence contains recognizable enoyl reductase (ER) domain features: a Rossmann-like NAD(P)H-binding motif ('GASTASGVLGIQFAKLSGFAPLA' with GxxGxxG spacing) and the catalytic YXXXD motif ('YTVFGEDWGMGTAHFPASGVDA'). Enoyl reductase domains are characteristic of polyketide synthase (PKS) and fatty acid synthase (FAS) biosynthetic machinery. This domain architecture is fundamentally incompatible with: (B) tRNA modification enzymes (which use radical SAM, thiolation, or methyltransferase folds); (C) dihydroxy-acid dehydratase for valine biosynthesis (an Fe-S cluster enzyme with a completely different fold); (D) one-carbon metabolism enzymes (SHMT, MTHFR, formyltransferases — none have ER domains). In fungi, standalone ER domains (not embedded in large FAS/PKS multi-domain proteins) are predominantly found in secondary metabolite biosynthetic gene clusters, many of which produce antifungal or antimicrobial compounds. Among the four options, only 'Antifungal biosynthesis' (A) is compatible with an enoyl reductase domain in a fungal protein context.",
    "missing_item_specific_fact": "",
    "reason": "The enoyl reductase domain features in the sequence allow elimination of options B, C, and D through domain-incompatibility reasoning. The positive assignment to 'Antifungal biosynthesis' follows from the transferable knowledge that standalone ER domains in fungal proteins are typically embedded in specialized secondary metabolite clusters, a large fraction of which produce antifungal compounds. This is a family-level inference from ER domain biology and fungal natural product chemistry, not a lookup of this specific protein's annotation."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The enoyl reductase domain is clearly incompatible with tRNA modification (B), amino acid biosynthesis (C), and one-carbon metabolism (D). Only option A is compatible with the observed domain architecture. No ambiguity among the offered choices."
  },
  "important_caveats": [
    "The positive identification of 'antifungal' specifically (rather than, say, 'polyketide biosynthesis' or 'fatty acid biosynthesis') relies on the elimination of the other three options plus the probabilistic association of fungal standalone ER domains with secondary metabolite clusters. The sequence alone does not encode 'antifungal' as a specific property.",
    "The UniProt annotation is from a 2024 experimental study (PubMed:39105744) characterizing the restricticin biosynthetic cluster in Aspergillus sclerotiorum. The pathway label 'Antifungal biosynthesis' is a UniProt-curated descriptor for this specific natural product pathway.",
    "The reviewer-only evidence confirms the sequence matches P0DXV9 exactly, but the organism identity and specific compound name (restricticin) were not provided to the evaluated model."
  ]
}
```

</details>

## Existing project source checks of the old Luna review only

These unchanged notes concern the earlier Luna claims. They do not validate either new review or the old Qwen review. No new scientific adjudication was performed.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Complete reviewer-only evidence and qualifications

All excerpts supplied in the original and revised reviewer user message follow. This material was not available to the original evaluated model. Accession identity came from dataset image-path metadata. Source support and transferable discrimination are separate judgments.

**Applicability metadata, unchanged:**

```json
{
  "requested_accession": "P0DXV9",
  "identity_origin": "reviewer-only accession inferred mechanically from original dataset image-path metadata; this accession/metadata was absent from evaluated model input",
  "benchmark_sequence_sha256": "9469ba1064baba46c4b8a0d5b1139bfae6c739cf6631aa8deeb889bb25b40b21",
  "benchmark_sequence_length": 357,
  "current_status": "retrieved",
  "current_sequence_comparison": "matched",
  "current_entry_audit": {
    "entryVersion": 6,
    "firstPublicDate": "2025-02-05",
    "lastAnnotationUpdateDate": "2026-09-02",
    "lastSequenceUpdateDate": "2025-02-05",
    "sequenceVersion": 1
  },
  "current_uniprot_release": "2026_03",
  "current_record_sha256": "0ea3f01218a5d44f3983e214db9b5571f37b981454f4a8fcafcef626a639e914",
  "current_source_sequence_sha256": "9469ba1064baba46c4b8a0d5b1139bfae6c739cf6631aa8deeb889bb25b40b21",
  "current_source_sequence_length": 357,
  "historical_status": "retrieved",
  "historical_cutoff_date": "2026-05-07",
  "historical_sequence_comparison": "matched",
  "selected_historical_entry_version": 4,
  "selected_historical_version": {
    "accession": "P0DXV9",
    "database": "Swiss-Prot",
    "entryVersion": 4,
    "firstRelease": "2026_01/2026_01",
    "firstReleaseDate": "28-Jan-2026",
    "lastRelease": "2026_01/2026_01",
    "lastReleaseDate": "28-Jan-2026",
    "name": "RESD_ASPSL",
    "sequenceVersion": 1
  },
  "selected_historical_record_sha256": "50948681abaa65d91ada1f1b7abe16915d33f113843973d2c3d87f65be73d5b0",
  "selected_historical_source_sequence_sha256": "9469ba1064baba46c4b8a0d5b1139bfae6c739cf6631aa8deeb889bb25b40b21",
  "selected_historical_source_sequence_length": 357,
  "latest_at_cutoff_sequence_comparison": "matched",
  "historical_sequence_versions_checked": [
    {
      "entry_version": 4,
      "exact_sequence_comparison": "matched",
      "sequence_version": 1
    }
  ],
  "actual_author_source_snapshot": "unknown",
  "numbering": "Canonical entry coordinates; construct or isoform numbering is not assumed."
}
```

**Qualifications, unchanged:**

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV9.json)

```json
{
  "evidence_id": "C1",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXV9.json",
  "source_sha256": "0ea3f01218a5d44f3983e214db9b5571f37b981454f4a8fcafcef626a639e914",
  "retrieved_utc": "2026-11-02T04:29:49.517632+00:00",
  "json_pointer": "/primaryAccession",
  "excerpt": "\"P0DXV9\"",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C2

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV9.json)

```json
{
  "evidence_id": "C2",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXV9.json",
  "source_sha256": "0ea3f01218a5d44f3983e214db9b5571f37b981454f4a8fcafcef626a639e914",
  "retrieved_utc": "2026-11-02T04:29:49.517632+00:00",
  "json_pointer": "/entryAudit",
  "excerpt": "{\"entryVersion\":6,\"firstPublicDate\":\"2025-02-05\",\"lastAnnotationUpdateDate\":\"2026-09-02\",\"lastSequenceUpdateDate\":\"2025-02-05\",\"sequenceVersion\":1}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C3

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV9.json)

```json
{
  "evidence_id": "C3",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXV9.json",
  "source_sha256": "0ea3f01218a5d44f3983e214db9b5571f37b981454f4a8fcafcef626a639e914",
  "retrieved_utc": "2026-11-02T04:29:49.517632+00:00",
  "json_pointer": "/organism",
  "excerpt": "{\"lineage\":[\"Eukaryota\",\"Fungi\",\"Dikarya\",\"Ascomycota\",\"Pezizomycotina\",\"Eurotiomycetes\",\"Eurotiomycetidae\",\"Eurotiales\",\"Aspergillaceae\",\"Aspergillus\",\"Circumdati\"],\"scientificName\":\"Aspergillus sclerotiorum\",\"taxonId\":138282}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV9.json)

```json
{
  "evidence_id": "C4",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXV9.json",
  "source_sha256": "0ea3f01218a5d44f3983e214db9b5571f37b981454f4a8fcafcef626a639e914",
  "retrieved_utc": "2026-11-02T04:29:49.517632+00:00",
  "json_pointer": "/proteinDescription",
  "excerpt": "{\"alternativeNames\":[{\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"39105744\",\"source\":\"PubMed\"}],\"value\":\"Restricticin biosynthesis cluster protein D\"}}],\"recommendedName\":{\"ecNumbers\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000305\",\"id\":\"39105744\",\"source\":\"PubMed\"}],\"value\":\"1.-.-.-\"}],\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"39105744\",\"source\":\"PubMed\"}],\"value\":\"Trans-enoyl reductase resD\"}}}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV9.json)

```json
{
  "evidence_id": "C5",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXV9.json",
  "source_sha256": "0ea3f01218a5d44f3983e214db9b5571f37b981454f4a8fcafcef626a639e914",
  "retrieved_utc": "2026-11-02T04:29:49.517632+00:00",
  "json_pointer": "/comments/1",
  "excerpt": "{\"commentType\":\"PATHWAY\",\"texts\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000269\",\"id\":\"39105744\",\"source\":\"PubMed\"}],\"value\":\"Antifungal biosynthesis\"}]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV9.json)

```json
{
  "evidence_id": "C6",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXV9.json",
  "source_sha256": "0ea3f01218a5d44f3983e214db9b5571f37b981454f4a8fcafcef626a639e914",
  "retrieved_utc": "2026-11-02T04:29:49.517632+00:00",
  "json_pointer": "/references/0",
  "excerpt": "{\"citation\":{\"authors\":[\"Lu Y.\",\"Li Y.\",\"Dou M.\",\"Liu D.\",\"Lin W.\",\"Fan A.\"],\"citationCrossReferences\":[{\"database\":\"PubMed\",\"id\":\"39105744\"},{\"database\":\"DOI\",\"id\":\"10.1021/acs.jafc.4c04244\"}],\"citationType\":\"journal article\",\"firstPage\":\"18520\",\"id\":\"39105744\",\"journal\":\"J. Agric. Food Chem.\",\"lastPage\":\"18527\",\"publicationDate\":\"2024\",\"title\":\"Discovery of a hybrid molecule with phytotoxic activity by genome mining, heterologous expression, and OSMAC strategy.\",\"volume\":\"72\"},\"referenceNumber\":1,\"referencePositions\":[\"NUCLEOTIDE SEQUENCE [GENOMIC DNA]\",\"FUNCTION\",\"PATHWAY\"]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence H1

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/P0DXV9?format=txt&versions=4)

```json
{
  "evidence_id": "H1",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/P0DXV9?format=txt&versions=4",
  "source_sha256": "50948681abaa65d91ada1f1b7abe16915d33f113843973d2c3d87f65be73d5b0",
  "retrieved_utc": "2026-11-02T04:29:51.221408+00:00",
  "source_locator": "lines 1-14",
  "excerpt": "ID   RESD_ASPSL              Reviewed;         357 AA.\nAC   P0DXV9;\nDT   05-FEB-2025, integrated into UniProtKB/Swiss-Prot.\nDT   05-FEB-2025, sequence version 1.\nDT   28-JAN-2026, entry version 4.\nDE   RecName: Full=Trans-enoyl reductase resD {ECO:0000303|PubMed:39105744};\nDE            EC=1.-.-.- {ECO:0000305|PubMed:39105744};\nDE   AltName: Full=Restricticin biosynthesis cluster protein D {ECO:0000303|PubMed:39105744};\nGN   Name=resD {ECO:0000303|PubMed:39105744};\nOS   Aspergillus sclerotiorum.\nOC   Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Eurotiomycetes;\nOC   Eurotiomycetidae; Eurotiales; Aspergillaceae; Aspergillus;\nOC   Aspergillus subgen. Circumdati.\nOX   NCBI_TaxID=138282;\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 4,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/P0DXV9?format=txt&versions=4)

```json
{
  "evidence_id": "H2",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/P0DXV9?format=txt&versions=4",
  "source_sha256": "50948681abaa65d91ada1f1b7abe16915d33f113843973d2c3d87f65be73d5b0",
  "retrieved_utc": "2026-11-02T04:29:51.221408+00:00",
  "source_locator": "lines 15-21",
  "excerpt": "RN   [1]\nRP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, AND PATHWAY.\nRX   PubMed=39105744; DOI=10.1021/acs.jafc.4c04244;\nRA   Lu Y., Li Y., Dou M., Liu D., Lin W., Fan A.;\nRT   \"Discovery of a hybrid molecule with phytotoxic activity by genome mining,\nRT   heterologous expression, and OSMAC strategy.\";\nRL   J. Agric. Food Chem. 72:18520-18527(2024).\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 4,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/P0DXV9?format=txt&versions=4)

```json
{
  "evidence_id": "H3",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/P0DXV9?format=txt&versions=4",
  "source_sha256": "50948681abaa65d91ada1f1b7abe16915d33f113843973d2c3d87f65be73d5b0",
  "retrieved_utc": "2026-11-02T04:29:51.221408+00:00",
  "source_locator": "lines 37-37",
  "excerpt": "CC   -!- PATHWAY: Antifungal biosynthesis. {ECO:0000269|PubMed:39105744}.\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 4,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/pathway.json), zero-based source row 81. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). [Source credits](../THIRD_PARTY_NOTICES.md).
